147 related articles for article (PubMed ID: 27604323)
1. Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin.
Ashton MP; Eugster A; Walther D; Daehling N; Riethausen S; Kuehn D; Klingel K; Beyerlein A; Zillmer S; Ziegler AG; Bonifacio E
Sci Rep; 2016 Sep; 6():32899. PubMed ID: 27604323
[TBL] [Abstract][Full Text] [Related]
2. Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus.
Klemetti P; Hyöty H; Roivainen M; Ilonen J; Savola K; Knip M; Akerblom HK; Vaarala O
J Clin Virol; 1999 Oct; 14(2):95-105. PubMed ID: 10588452
[TBL] [Abstract][Full Text] [Related]
3. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65).
Vreugdenhil GR; Batstra MR; Aanstoot HJ; Melchers WJ; Galama JM
J Med Virol; 1999 Oct; 59(2):256-61. PubMed ID: 10459165
[TBL] [Abstract][Full Text] [Related]
4. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes.
Cainelli F; Manzaroli D; Renzini C; Casali F; Concia E; Vento S
Diabetes Care; 2000 Jul; 23(7):1021-2. PubMed ID: 10895859
[No Abstract] [Full Text] [Related]
5. The pathogenesis of viral-induced diabetes.
See DM; Tilles JG
Clin Diagn Virol; 1998 Apr; 9(2-3):85-8. PubMed ID: 9645989
[TBL] [Abstract][Full Text] [Related]
6. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.
Frisk G; Tuvemo T
J Med Virol; 2004 Jul; 73(3):450-9. PubMed ID: 15170642
[TBL] [Abstract][Full Text] [Related]
8. Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes.
Kukreja A; Maclaren NK
Cell Mol Life Sci; 2000 Apr; 57(4):534-41. PubMed ID: 11130453
[TBL] [Abstract][Full Text] [Related]
9. Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent.
Jeong SY; Ahn J; Cho YJ; Kim YJ; Kim DS; Jee Y; Lee H; Nam JH
Microbiol Immunol; 2007; 51(11):1091-8. PubMed ID: 18037786
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
Atkinson MA; Bowman MA; Campbell L; Darrow BL; Kaufman DL; Maclaren NK
J Clin Invest; 1994 Nov; 94(5):2125-9. PubMed ID: 7962558
[TBL] [Abstract][Full Text] [Related]
11. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry.
Horwitz MS; Bradley LM; Harbertson J; Krahl T; Lee J; Sarvetnick N
Nat Med; 1998 Jul; 4(7):781-5. PubMed ID: 9662368
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
13. Investigation of enterovirus infections, autoimmune factors and HLA genotypes in patients with T1DM.
Çekin Y; Özkaya E; Gülkesen H; Akçurin S; Çolak D
Minerva Endocrinol; 2014 Mar; 39(1):67-74. PubMed ID: 24513606
[TBL] [Abstract][Full Text] [Related]
14. Course of coxsackie B antibodies during juvenile diabetes.
Schmidt WA; Brade L; Müntefering H; Klein M
Med Microbiol Immunol; 1978; 164(4):291-8. PubMed ID: 45604
[TBL] [Abstract][Full Text] [Related]
15. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.
Chehadeh W; Lobert PE; Sauter P; Goffard A; Lucas B; Weill J; Vantyghem MC; Alm G; Pigny P; Hober D
J Virol; 2005 Nov; 79(22):13882-91. PubMed ID: 16254324
[TBL] [Abstract][Full Text] [Related]
16. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.
Palmer JP; Cooney MK; Ward RH; Hansen JA; Brodsky JB; Ray CG; Crossley JR; Asplin CM; Williams RH
Diabetologia; 1982 Jun; 22(6):426-9. PubMed ID: 6286394
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
18. Coxsackie virus and diabetes revisited.
Jones DB; Armstrong NW
Nat Med; 1995 Apr; 1(4):284. PubMed ID: 7585050
[No Abstract] [Full Text] [Related]
19. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
20. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.
Horwitz MS; Fine C; Ilic A; Sarvetnick N
J Autoimmun; 2001 May; 16(3):211-7. PubMed ID: 11334485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
